HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patientsCheng‐Yuan Peng, Jia‐Horng Kao, Chih‐Lin Lin et al.|Journal of the Formosan Medical Association|2013Cited by 14
Enteral Access Potentially Endangers Esophageal Carcinoma Patients Under Multi-modality Therapy: A Population-based StudyChun-Hou Huang, Tai‐Chu Peng, Tsung‐Cheng Hsieh et al.|Anticancer Research|2019Cited by 2